Nocardia Rubra Cell Wall Skeleton
- Generic Name
- Nocardia Rubra Cell Wall Skeleton
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
Phase 1
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Hepatic arterial infusion chemotherapy
- First Posted Date
- 2022-09-09
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Wan-Guang Zhang
- Target Recruit Count
- 30
- Registration Number
- NCT05533892
- Locations
- 🇨🇳
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
Phase 4
- Conditions
- Diabetic Foot UlcerTherapy, Directly Observed
- Interventions
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2022-05-10
- Target Recruit Count
- 116
- Registration Number
- NCT05368142
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath